
COVIDãã³ãããã¯ã®è²¬ä»»ã¯Modernaããã«ã»ã²ã€ãããã¡ãŠãå士ã«ããïŒ- ç±³åœåœé²ç·çã¯COVIDã®ååšãç¥ããã3ã¶æåã«ãCOVID-19ç ç©¶ãå¥çŽãçºè¡ããFauciãšModernaã¯2019幎12æã«ã¯ã¯ãã³ãæºåããŠããã
å èšäºã¯ãã¡ããã/Click here to read the original article.
2019幎11æã«ç±³åœåœé²ç·çãLabyrinth Global Healthã«ãCOVID-19ç ç©¶ãã®ããã«çºæ³šããå¥çŽãçºèŠãããããšã§ãæ°åã³ãããŠã€ã«ã¹ã«é¢ããç±³åœæ¿åºã®æ°žä¹
çãªç¥èã«ã€ããŠçåãåãããŠããŸãã
ãã®å¥çŽã¯ãããŠã¯ã©ã€ãã«ãããçç©åŠçè
åšè»œæžããã°ã©ã ãã®ããã®ãã倧ããªãããžã§ã¯ãã®äžéšã§ããã2019幎12æã«äžåœã®æŠæŒ¢ã§æ¡æ£ããåã«ãæ°žä¹
çãªç±³åœæ¿åºãå°ãªããšãçæã®ãŠã€ã«ã¹ãèªèããŠããããšã瀺åããŠããŸãã
ããããä»åã®èª¿æ»çµæã¯ãã¢ã³ãœããŒã»ãã¡ãŠãå士ãç£ç£ããã²ã€ã³ã»ãªãã»ãã¡ã³ã¯ã·ã§ã³ã»ãªãµãŒããéããŠãç±³åœæ¿åºã®æ°žä¹ æ©é¢ããã€ãªã©ãã§ãã®çæã®ãŠã€ã«ã¹ã®äœæã«æã貞ããå¯èœæ§ã瀺åããŠããŸãã
ããã«ãã£ãŠãäžçä¿å¥æ©é¢ã2020幎2æã«Covid-19ãšæ£åŒã«åœåãã3ã«æåã«ã圌ããæ°åã³ãããŠã€ã«ã¹ã®ç åãç¥ã£ãŠããããšã説æã§ããã
ãããŠãModernaãšFauciã®åœç«ã¢ã¬ã«ã®ãŒææçç ç©¶æïŒNIAIDïŒã2019幎12æäžæ¬ã«mRNAã³ãããŠã€ã«ã¹ã¯ã¯ãã³åè£ã®æ©å¯ä¿æå¥çŽãç· çµããå ±åéçºããçç±ã説æã§ããã ããã

ç±³åœæ¿åºã®ãUSA SpendingããŠã§ããµã€ãã¯ããCOVID-19ã«å¯Ÿå¿ããããã«ã4å 400åãã«ãšããéæ¹ããªãéé¡ãæ¯åºããããšãæããã«ããŠãããåãµã€ãã®ãè³éæ€çŽ¢ãæ©èœã詳ããèŠããšãåœé²ç·çã2012幎9æ20æ¥ã«ãã©ãã¯ã»ã¢ã³ãã»ãŽã£ãŒãã»ã¹ãã·ã£ã«ã»ãããžã§ã¯ã瀟ã«çºæ³šãããå°éãç§åŠãæè¡ãµãŒãã¹ãã®å¥çŽãçºèŠãããã
åå¥çŽã®ããµãã¢ã¯ãŒããã¿ãã詳ãã調ã¹ããšã115ä»¶ã®ååŒã«åå人ãšç°¡åãªèª¬æãããããã®å€§åã¯ãããšãã®å®éšåšå ·ãããããšãã®ãªãã£ã¹å®¶å ·ãã®ãããªãããµãããã®ã§ããããšããããã

ããããç±³åœåœé²ç·çãBlack & Veatch Special Projects Corp.ã«çºæ³šããå¥çŽã®ãSub-Awardsãã¿ãã«èšèŒãããŠãã115ä»¶ã®ååŒã®äžã«ãã²ãšããç®ãåŒããã®ãããã
Labyrinth Global Health INCã«å¯Ÿãã ãSME Manuscript Documentation and COVID-19 Research ãã®åè³ã§ãã
ãã³ãããã¯æã«Covid-19ç ç©¶ã®ããã®è³ãããããšã¯é©ãã¹ãããšã§ã¯ãªããããã®å¥çŽããæ°åã³ãããŠã€ã«ã¹ã®åºçŸãçãããå°ãªããšã1ã«æåãCovid-19ãšæ£åŒã«åä»ãããã3ã«æåã®2019幎11æ12æ¥ã«æäžãããŠãããšããäºå®ã¯ãæ¿åºã®ãŠã€ã«ã¹ã«é¢ããç¥èã«ã€ããŠçåãæãããããã®ã§ããã

ããã«ãBlack & Veatch Special Projects Corp.ã«çºæ³šãããå¥çŽå šäœãšåæ§ã«ããŠã¯ã©ã€ãã§è¡ãããããæç€ºãããŠããŸããããããã®ããšããããŠã€ã«ã¹ã®äœæã𿡿£ã«ç±³åœæ¿åºãé¢äžããŠããå¯èœæ§ã瀺åãããŸããã
2012幎9æãç±³åœåœé²ç·çã®åœé²è åšåæžå±ïŒDTRAïŒã¯ãã€ã³ãã©æŽåãå°éãšããã°ããŒãã«ãªãšã³ãžãã¢ãªã³ã°ã調éã建èšäŒç€Ÿã«å¥çŽãçºæ³šããŸããã

ãã®å¥çŽã¯ããŠã¯ã©ã€ãã«ãããçç©åŠçè åšè»œæžããã°ã©ã ã«é¢ãããã®ã§ã2020幎10æã«ç· çµãããã詳现ã¯äžæã ãã1å1660äžãã«ã®å¥çŽã®ãã¡ã2170äžãã«ããã®ããã°ã©ã ã«è²»ããããããšãåãã£ãŠããã

DODãçç©åŠçè åšã®åæžããã°ã©ã ã®ããã«ãã€ã³ãã©æŽåãå°éãšããäŒæ¥ãšå¥çŽããçç±ã¯äžå¯è§£ã§ããã
ããã«ãDODãšå¥çŽäŒç€Ÿã®äž¡æ¹ããæ°åã³ãããŠã€ã«ã¹ãåºçŸããåãCOVID-19ãšæ£åŒã«åœåãããåã«ããŠã¯ã©ã€ãã§COVID-19ç ç©¶ãè¡ãããã«ã©ããªã³ã¹ã»ã°ããŒãã«ã»ãã«ã¹ç€Ÿã«æ¯æã£ãããšã¯è峿·±ãããšã§ããã
ãããã®åºæ¥äºã¯ãçç©åŠçè åšåæžããã°ã©ã ã®æ§è³ªãšãçæã®COVID-19ãã³ãããã¯ãšã®æœåšçãªé¢é£æ§ã«ã€ããŠçåãæãããããã®ã§ããããããŠã2019幎11æã«ç±³åœåœé²ç·çãCovid-19ç ç©¶ã®ããã«çºæ³šããå¥çŽãçºèŠãããããšã¯ãç±³åœæ¿åºããã®ãŠã€ã«ã¹ãèªç¶ã«ååšããããšãç¥ã£ãŠããããç 究宀ã§ã®æ§ç¯ã«é¢äžããŠããããšã瀺åããŠããŸãã
ãã®èª¬ã¯ã2019幎12æã«åœç«ã¢ã¬ã«ã®ãŒã»ææçç ç©¶æïŒNIAIDïŒãšModernaãã³ãããŠã€ã«ã¹åè£ãä¿æããŠãããšãã蚌æ ã«ãã£ãŠè£ä»ããããŠããŸãã
æ©å¯ä¿æå¥çŽã«ãããNIAIDãšModernaã2019幎12æ12æ¥ã«ãmRNAã³ãããŠã€ã«ã¹ã¯ã¯ãã³åè£ããããŒã¹ã«ãã©ã€ã倧åŠãã£ãã«ãã«æ ¡ã«è²æž¡ããããšã«åæããããšãæããã«ãªã£ãŠããŸãã

ææè²æž¡å¥çŽã¯ã2019幎12æ12æ¥ã«ããŒã¹ã«ãã©ã€ã倧åŠãã£ãã«ãã«æ ¡ã®Ralph Baric, PhDã眲åãããã®åŸã2019幎12æ16æ¥ã«ããŒã¹ã«ãã©ã€ã倧åŠã©ã€ã»ã³ã¹ã»ã€ãããŒã·ã§ã³ãµããŒãæ åœãã£ã¬ã¯ã¿ãŒã®Jacqueline Quayã眲åããŠããŸãã

ãŸããæ¬å¥çŽã¯NIAIDã®ä»£è¡šè 2åã眲åããŠããããã®ãã¡ã®1åã¯Amy F. Petrik PhDïŒæè¡ç§»è»¢å°éå®¶ïŒã§ã2019幎12æ12æ¥åå8æ5åã«å¥çŽæžã«çœ²åããŠããŸãããã1人ã®çœ²åè ã¯ãNIAIDã®ç ç©¶å¡ã§ããBarney Graham MD PhDã§ãããããã®çœ²åã«ã¯æ¥ä»ããããŸããã§ããã

æ¬å¥çŽã®æçµçœ²åè ã¯ãã¢ããã®èª¿æ»å¡ã§ããSunny Himansuãšãã¢ããã®å¯é¡§åã§ããShaun Ryanã§ããäž¡è ã®çœ²åã¯ã2019幎12æ17æ¥ã«è¡ãããŸããã

ãããã®çœ²åã¯ãã¹ãŠãæ°åã³ãããŠã€ã«ã¹ã®åºçŸãçãããããšãäžè¬åžæ°ãç¥ãåã«è¡ããããã®ã§ããã
ãã«ã»ã²ã€ããšãã®è²¡å£ãè³éãæäŸããã¯ã¯ãã³åè£ã
ã¢ããã¯2016幎ããã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ããããåèšåºã«ãããæäœã®çµã¿åããã®è©äŸ¡ã«é¢ããåæãããžã§ã¯ããããã³æœåšçãªmRNAå»è¬åã®ããåãšãªã第1çžèšåºè©Šéšã®å®æœããæ¯æŽããããã«2000äžãã«ãäŸäžãããããšã確èªããŸããã

ããããã¢ããã¯ããã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ãšçµãã æ çµã¿åæã«ããããã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ã«ææ¡ãæ¿èªãããããã©ããŒãªã³ã»ãããžã§ã¯ããã«å¯ŸããŠã2022幎ãŸã§ã«è³éç·é¡ãæå€§1åãã«ã«ããããšãã§ãããšæããã«ããŸããã
ãããŠãæ¬å¥çŽã®æ¡ä»¶ãšããŠãã¢ããã¯ãã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ã«äžå®ã®éç¬å çã©ã€ã»ã³ã¹ãä»äžãã矩åããããšèŠå®ãããŠããŸãã
éç¬å çã©ã€ã»ã³ã¹ãšã¯ãã©ã€ã»ã³ã·ãŒã«ç¥ç財ç£ã䜿çšããæš©å©ãäžãããã®ã§ãããã©ã€ã»ã³ãµãŒã¯åãç¥ç財ç£ãèªç±ã«å©çšããä»ã®ã©ã€ã»ã³ã·ãŒã«ãåãç¥ç財ç£ãå©çšããããšãèš±å¯ããããšãæå³ããŸãã
ãããã£ãŠãã¢ãã瀟ãšã®å¥çŽã«ããããã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ã¯ãã¢ãã瀟補mRNAã³ããã19æ³šå°æ¶²ã®éç¬å çã©ã€ã»ã³ã¹ãä»äžããããã®äœ¿çšã«ããå©çãåŸãŠããŸãã
COVIDãã³ãããã¯ã®è²¬ä»»ã¯FauciãGatesãModernaã«ããã®ãïŒ
äžçä¿å¥æ©é¢ïŒWHOïŒããäžåœã®æŠæŒ¢ã§ãŠã€ã«ã¹æ§èºçã®é壿æçæãææ¡ããã®ã¯ã2019幎12æ31æ¥ã®ããšã§ããã
ãããããã®æç¹ã§ããçæã®æ°åã³ãããŠã€ã«ã¹ãåå ã§ãããšã¯æå®ããŠãããã代ããã«èºçã¯ãåå äžæãã§ãããšè¿°ã¹ãŠããŸããã

WHOããäžåœåœå±ããã®ã¢ãŠããã¬ã€ã¯ãåŸã«SARS-CoV-2ãšåŒã°ããããã«ãªã£ãæ°åã³ãããŠã€ã«ã¹ã«ãããã®ã ãšå€æãããšå ±åããã®ã¯ã2020幎1æ9æ¥ã®ããšã§ããã®çµæçãããšãããçŸæ£ã¯COVID-19ãšåŒã°ããã
ã§ã¯ããªã2019幎12æ12æ¥ã«Moderna瀟ãäœæããã³ãããŠã€ã«ã¹ã¯ã¯ãã³ãããŒã¹ã«ãã©ã€ã倧åŠã«è²æž¡ãããã®ã§ããããïŒ
Covid-19ãšæŠããšãããmRNAã³ãããŠã€ã«ã¹ã¯ã¯ãã³ãè±åœãšç±³åœã®äž¡æ¹ã§ç·æ¥äœ¿çšã®ã¿èªå¯ãããã®ãšåãModerna瀟ã§ãã
ModernaãFauciãBill Gatesã¯ãç§ãã¡ãç¥ããªãããšãäœãç¥ã£ãŠããã®ã§ããããïŒ
2019幎ã«ã¯ãã¯ã¯ãã³ãå¿ èŠãšãããããªäººé¡ãžã®è åšãããããç¹ç°ãªã³ãããŠã€ã«ã¹ã¯ååšããŸããã§ããã
äžçãåã«é²ãããšããäžãçãã®ãªãå€ãã®çåãæ®ã£ãŠãããäžèšã¯ãã®äžéšã§ããã
ãããã2019幎11æã«ç±³åœåœé²ç·çãCovid-19ç ç©¶ã®ããã«çºæ³šããå¥çŽãçºèŠãããModernaãšFauciã®NIAIDã2019幎12æã«ãã«ã»ã²ã€ããè³éæäŸããmRNAã³ãããŠã€ã«ã¹ã¯ã¯ãã³åè£ãæºåããŠãããšããäºå®ã¯ãæ°žä¹ ã«ç¶ãç±³åœæ¿åºãã¢ã³ãœããŒFauciå士ããã«ã»ã²ã€ãæ°ïŒModernaãããããã®è³ªåã®çããç¥ã£ãŠããããšã瀺ããŠããŸãã